Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 22

    1.

    Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.

    Hu Z, Dong J, Wang LE, Ma H, Liu J, Zhao Y, Tang J, Chen X, Dai J, Wei Q, Zhang C, Shen H.

    Carcinogenesis. 2012 Apr;33(4):828-34. Epub 2012 Feb 1.

    PMID:
    22298638
    [PubMed - indexed for MEDLINE]
    2.

    Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cells.

    Montales MT, Rahal OM, Kang J, Rogers TJ, Prior RL, Wu X, Simmen RC.

    Carcinogenesis. 2012 Mar;33(3):652-60. Epub 2012 Jan 4.

    PMID:
    22219179
    [PubMed - indexed for MEDLINE]
    3.

    PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer.

    Riggio M, Polo ML, Blaustein M, Colman-Lerner A, Lüthy I, Lanari C, Novaro V.

    Carcinogenesis. 2012 Mar;33(3):509-18. Epub 2011 Dec 17.

    PMID:
    22180571
    [PubMed - indexed for MEDLINE]
    4.

    The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes.

    Teo MT, Landi D, Taylor CF, Elliott F, Vaslin L, Cox DG, Hall J, Landi S, Bishop DT, Kiltie AE.

    Carcinogenesis. 2012 Mar;33(3):581-6. Epub 2011 Dec 12.

    PMID:
    22166496
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer.

    Mabrok HB, Klopfleisch R, Ghanem KZ, Clavel T, Blaut M, Loh G.

    Carcinogenesis. 2012 Jan;33(1):203-8. Epub 2011 Nov 10.

    PMID:
    22080573
    [PubMed - indexed for MEDLINE]
    7.

    Telomere length variation in normal epithelial cells adjacent to tumor: potential biomarker for breast cancer local recurrence.

    Zhou X, Meeker AK, Makambi KH, Kosti O, Kallakury BV, Sidawy MK, Loffredo CA, Zheng YL.

    Carcinogenesis. 2012 Jan;33(1):113-8. Epub 2011 Nov 9.

    PMID:
    22072619
    [PubMed - indexed for MEDLINE]
    8.

    Activation of the mTOR pathway by low levels of xenoestrogens in breast epithelial cells from high-risk women.

    Goodson WH 3rd, Luciani MG, Sayeed SA, Jaffee IM, Moore DH 2nd, Dairkee SH.

    Carcinogenesis. 2011 Nov;32(11):1724-33. Epub 2011 Sep 1.

    PMID:
    21890461
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study.

    Healey CS, Ahmed S; ANECS; AOCS Management Group, O'Mara TA, Ferguson K; LES, Lambrechts D, Garcia-Dios DA, Vergote I, Amant F; NSECG, Howarth K, Gorman M, Hodgson S, Tomlinson I; PECS, Yang HP, Lissowska J, Brinton LA, Chanock S, Garcia-Closas M; SASBAC, Hall P, Liu J; SEARCH, Shah M, Pharoah PD, Thompson DJ; WISE, Rebbeck TR, Strom BL, Dunning AM, Easton DF, Spurdle AB.

    Carcinogenesis. 2011 Dec;32(12):1862-6. Epub 2011 Sep 30.

    PMID:
    21965274
    [PubMed - indexed for MEDLINE]
    10.

    Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferase.

    Derfoul A, Juan AH, Difilippantonio MJ, Palanisamy N, Ried T, Sartorelli V.

    Carcinogenesis. 2011 Nov;32(11):1607-14. Epub 2011 Aug 8.

    PMID:
    21828058
    [PubMed - indexed for MEDLINE]
    11.

    CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells.

    Ju JH, Jang K, Lee KM, Kim M, Kim J, Yi JY, Noh DY, Shin I.

    Carcinogenesis. 2011 Oct;32(10):1474-83. Epub 2011 Jul 27.

    PMID:
    21798852
    [PubMed - indexed for MEDLINE]
    12.

    Deletion of cyclooxygenase 2 in mouse mammary epithelial cells delays breast cancer onset through augmentation of type 1 immune responses in tumors.

    Markosyan N, Chen EP, Ndong VN, Yao Y, Sterner CJ, Chodosh LA, Lawson JA, Fitzgerald GA, Smyth EM.

    Carcinogenesis. 2011 Oct;32(10):1441-9. Epub 2011 Jul 18.

    PMID:
    21771729
    [PubMed - indexed for MEDLINE]
    13.

    Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway.

    Sun H, Hu Y, Gu Z, Owens RT, Chen YQ, Edwards IJ.

    Carcinogenesis. 2011 Oct;32(10):1518-24. Epub 2011 Jul 18.

    PMID:
    21771724
    [PubMed - indexed for MEDLINE]
    14.

    Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer.

    Smith TR, Liu-Mares W, Van Emburgh BO, Levine EA, Allen GO, Hill JW, Reis IM, Kresty LA, Pegram MD, Miller MS, Hu JJ.

    Carcinogenesis. 2011 Sep;32(9):1354-60. Epub 2011 Jun 23.

    PMID:
    21700777
    [PubMed - indexed for MEDLINE]
    15.

    Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells.

    Marconett CN, Sundar SN, Tseng M, Tin AS, Tran KQ, Mahuron KM, Bjeldanes LF, Firestone GL.

    Carcinogenesis. 2011 Sep;32(9):1315-23. Epub 2011 Jun 21.

    PMID:
    21693539
    [PubMed - indexed for MEDLINE]
    16.

    Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study.

    Roberts MR, Shields PG, Ambrosone CB, Nie J, Marian C, Krishnan SS, Goerlitz DS, Modali R, Seddon M, Lehman T, Amend KL, Trevisan M, Edge SB, Freudenheim JL.

    Carcinogenesis. 2011 Aug;32(8):1223-30. Epub 2011 May 27.

    PMID:
    21622940
    [PubMed - indexed for MEDLINE]
    17.

    Prevention of carcinogenesis and inhibition of breast cancer tumor burden by dietary stearate.

    Li C, Zhao X, Toline EC, Siegal GP, Evans LM, Ibrahim-Hashim A, Desmond RA, Hardy RW.

    Carcinogenesis. 2011 Aug;32(8):1251-8. Epub 2011 May 17.

    PMID:
    21586513
    [PubMed - indexed for MEDLINE]
    18.

    Macrophages induce COX-2 expression in breast cancer cells: role of IL-1β autoamplification.

    Hou Z, Falcone DJ, Subbaramaiah K, Dannenberg AJ.

    Carcinogenesis. 2011 May;32(5):695-702. Epub 2011 Feb 10.

    PMID:
    21310944
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Breast cancer stem cells: treatment resistance and therapeutic opportunities.

    Al-Ejeh F, Smart CE, Morrison BJ, Chenevix-Trench G, López JA, Lakhani SR, Brown MP, Khanna KK.

    Carcinogenesis. 2011 May;32(5):650-8. Epub 2011 Feb 10. Review.

    PMID:
    21310941
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells.

    Rodriguez BA, Weng YI, Liu TM, Zuo T, Hsu PY, Lin CH, Cheng AL, Cui H, Yan PS, Huang TH.

    Carcinogenesis. 2011 Jun;32(6):812-21. Epub 2011 Feb 8.

    PMID:
    21304052
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk